Difference between revisions of "SPECT Biomarker Ctte"
Jump to navigation
Jump to search
Line 1: | Line 1: | ||
+ | {{TOCright}} | ||
:Co-chairs: Yuni Dewaraja, PhD; P. David Mozley, MD; John Seibyl, MD | :Co-chairs: Yuni Dewaraja, PhD; P. David Mozley, MD; John Seibyl, MD | ||
:Secretary: Julie Lisiecki | :Secretary: Julie Lisiecki | ||
Line 5: | Line 6: | ||
==Project Snapshot== | ==Project Snapshot== | ||
The SPECT Biomarker Committee seeks to develop a quantitative imaging profile for SPECT imaging. | The SPECT Biomarker Committee seeks to develop a quantitative imaging profile for SPECT imaging. | ||
− | |||
'''Under consideration:''' | '''Under consideration:''' | ||
Line 11: | Line 11: | ||
*quantifying organs, like the liver, for dosimetry as potential use cases | *quantifying organs, like the liver, for dosimetry as potential use cases | ||
− | + | '''Established Task Forces currently working toward a first Profile titled: | |
− | '''Established Task Forces | ||
<font color=blue>''Quantifying Dopamine Transporters with 123-Iodine labeled Ioflupane in Neurodegenerative Disease''</font> | <font color=blue>''Quantifying Dopamine Transporters with 123-Iodine labeled Ioflupane in Neurodegenerative Disease''</font> | ||
Line 23: | Line 22: | ||
==Meetings/Call Summaries== | ==Meetings/Call Summaries== | ||
*[[SPECT Call Summaries]] | *[[SPECT Call Summaries]] | ||
− | |||
− | |||
− | |||
==Literature Review (Profile 1.0)== | ==Literature Review (Profile 1.0)== | ||
Line 54: | Line 50: | ||
*[[Media:001.QIBA_SPECT_Profile.v0.1_2016.02.17.docx | QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease - {comments from Mr. Cella}]] ''February 17, 2016'' | *[[Media:001.QIBA_SPECT_Profile.v0.1_2016.02.17.docx | QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease - {comments from Mr. Cella}]] ''February 17, 2016'' | ||
− | + | *[[Profile drafts|Archived past versions of the Profile]] | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
==Reference Materials== | ==Reference Materials== | ||
Revision as of 20:26, 17 March 2017
- Co-chairs: Yuni Dewaraja, PhD; P. David Mozley, MD; John Seibyl, MD
- Secretary: Julie Lisiecki
- Roster: (Roster)
Project Snapshot
The SPECT Biomarker Committee seeks to develop a quantitative imaging profile for SPECT imaging.
Under consideration:
- quantifying a small structure (like the basal ganglion in the DaTscan, thyroid)
- quantifying organs, like the liver, for dosimetry as potential use cases
Established Task Forces currently working toward a first Profile titled:
Quantifying Dopamine Transporters with 123-Iodine labeled Ioflupane in Neurodegenerative Disease
- Image Acquisition and Image Processing for DaTscan – Dr. Dewaraja
- Quantitative / Image Analysis – Drs. Miyaoka and Seibyl
- Phantoms / DRO Group – Drs. Dickson and Zimmerman
- Clinical / Literature Review – Dr. Seibyl
Meetings/Call Summaries
Literature Review (Profile 1.0)
- QIBA Literature Review Slides for Profile 1.0 - Dr. Seibyl March 22, 2016
Profile Development
- QIBA DRAFT Profile with tracked changes - {Dr. Mozley} April 15, 2016
- QIBA DRAFT Profile with tracked changes for recent additions and homework - {Dr. E. Frey} April 5, 2016
- QIBA DRAFT Profile - {Dr. Miyaoka} March 15, 2016
- QIBA DRAFT Profile: Quantifying Dopamine Transporters with 123-Iodine Labeled Ioflupane in Neurodegenerative Disease - {comments from Mr. Cella} February 17, 2016
Reference Materials
- QIBA SPECT TF presentation slides - Dr. Seibyl August 23, 2016
- QIBA SPECT BC presentation slides - Dr. Mozley July 15, 2016
- QIBA SPECT BC presentation slides - Dr. Miyaoka July 12, 2016
- QIBA SPECT BC presentation slides - Dr. Miyaoka May l0, 2016
- QIBA SPECT BC presentation slides - Dr. Dewaraja May 5, 2016
- QIBA SPECT BC presentation slides - Dr. Miyaoka April 22, 2016
- QIBA SPECT BC presentation slides - Dr. Seibyl March 8, 2016
- QIBA SPECT BC presentation slides - Dr. Frey February 2, 2016
- QIBA SPECT BC presentation slides - Dr. Buchert February 2, 2016
- QIBA SPECT BC presentation slides - Dr. Seibyl January 22, 2016
- I-123 DAT SCAN - Acquisition and Reconstruction Task Force presentation slides - Dr. Dewaraja January 5, 2016
- QIBA Claim Statement Types - Dr. Obuchowski November 20, 2015
- 03.20.2015 Link to papers of the group in Umeå that are collaborating with Dr. Ljungberg:
- The PI for this is Anne Larsson, PhD: http://www.ncbi.nlm.nih.gov/pubmed/?term=dat+scan+Larsson+A